Keerthi Prasad


Dr. Rachel Amiya is a public health researcher with significant international experience in Asia and Europe. Her most recent appointment was as an Assistant Professor at the University of Tokyo’s Graduate School of Medicine, with research interests and pursuits spanning diverse areas including quality of life, non-communicable diseases (NCDs), health behavior change, tobacco control, HIV/AIDS, and health systems strengthening. Based on such research, Dr. Amiya has authored/co-authored numerous scientific articles published in international peer-reviewed journals, along with several commentaries and book chapters. She is passionate about the potential for innovation and technology to enhance quality of life, save lives, and bridge inequities in health care quality and accessibility globally.

Outside of her academic engagements, Dr. Amiya has served on the board of the NCD Asia Pacific Alliance; as an Adjunct Research Fellow with the Department of Health Policy at the National Center for Child Health and Development; and as a Visiting Fellow with the Rebuild Japan Initiative Foundation, an independent think tank founded in response to the disasters surrounding the Great East Japan Earthquake of 2011. She has also worked with major international global health organizations including the World Health Organization, United Nation’s Children’s Fund (UNICEF), and Program for Appropriate Technology in Health (PATH).

Dr. Amiya has studied, worked, and traveled around the world; indeed, nearly half of her life has been spent outside the United States. After completing the International Baccalaureate program at the International School of Hamburg in Germany, she received her B.A. from Swarthmore College in Pennsylvania, going on to earn her Master’s and Doctoral degrees in Global Health Sciences from the University of Tokyo. Dr. Amiya’s international perspective and wide-ranging professional and academic experiences afford her unique insights with which to ideate, create, and evaluate innovative technologies for transformative global impact.